- Home
- DUOT vs CNTX Comparison
DUOT vs CNTX Comparison
Compare DUOT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOT
- CNTX
- Stock Information
- Founded
- DUOT 1990
- CNTX 2015
- Country
- DUOT United States
- CNTX United States
- Employees
- DUOT N/A
- CNTX N/A
- Industry
- DUOT Computer Software: Prepackaged Software
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- DUOT Technology
- CNTX Health Care
- Exchange
- DUOT Nasdaq
- CNTX Nasdaq
- Market Cap
- DUOT 66.3M
- CNTX 78.0M
- IPO Year
- DUOT N/A
- CNTX 2021
- Fundamental
- Price
- DUOT $7.23
- CNTX $0.73
- Analyst Decision
- DUOT Strong Buy
- CNTX Strong Buy
- Analyst Count
- DUOT 2
- CNTX 5
- Target Price
- DUOT $12.50
- CNTX $5.50
- AVG Volume (30 Days)
- DUOT 145.9K
- CNTX 152.6K
- Earning Date
- DUOT 08-12-2025
- CNTX 08-06-2025
- Dividend Yield
- DUOT N/A
- CNTX N/A
- EPS Growth
- DUOT N/A
- CNTX N/A
- EPS
- DUOT N/A
- CNTX N/A
- Revenue
- DUOT $11,162,390.00
- CNTX N/A
- Revenue This Year
- DUOT $294.36
- CNTX N/A
- Revenue Next Year
- DUOT $43.87
- CNTX N/A
- P/E Ratio
- DUOT N/A
- CNTX N/A
- Revenue Growth
- DUOT 89.27
- CNTX N/A
- 52 Week Low
- DUOT $2.03
- CNTX $0.49
- 52 Week High
- DUOT $9.27
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- DUOT 45.98
- CNTX 63.77
- Support Level
- DUOT $7.11
- CNTX $0.62
- Resistance Level
- DUOT $8.20
- CNTX $0.67
- Average True Range (ATR)
- DUOT 0.49
- CNTX 0.05
- MACD
- DUOT -0.04
- CNTX 0.01
- Stochastic Oscillator
- DUOT 18.99
- CNTX 90.63
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.